Comment Request, 75171 [2012-30367]

Download as PDF Federal Register / Vol. 77, No. 244 / Wednesday, December 19, 2012 / Notices 10.3109/17435390.2011.648223. Sung JH, Ji HJ, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ, Lee JH, Yu IJ [2008]. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhalation Toxicol 20:567–574. Sung JH, Ji, JH, Park JD, Yoon, JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JE, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ [2009]. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–461. Dated: December 12, 2012. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2012–30515 Filed 12–18–12; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families sroberts on DSK5SPTVN1PROD with Comment Request Title: Mother and Infant Home Visiting Program Evaluation—Strong Start: Data collection. Description: In September 2012, the Administration for Children and Families (ACF), the Centers for Medicare and Medicaid Services (CMS), and the Health Resources and Services Administration (HRSA) within the U.S. Department of Health and Human Services (HHS) launched an evaluation called the Mother and Infant Home Visiting Program Evaluation—Strong Start (MIHOPE—Strong Start). The study will evaluate the effectiveness of two evidence-based home visiting models—Healthy Families America and Nurse Family Partnership—at improving birth outcomes for women who are enrolled in Medicaid. The evaluation is part of the Strong Start for Mothers and Newborns initiative, which is informing the federal government about the effects of prenatal interventions that may provide better care, improved health, and reduced medical costs by improving birth outcomes. Data collected for MIHOPE-Strong Start will include the following: (1) A 20-minute baseline family survey, (2) two-hour semi-structured interviews with state administrators of the Maternal, Infant, and Early Childhood Home Visiting program, (3) web-based surveys with program managers of local home visiting programs, and (4) webbased surveys with home visitors in those programs. In addition, the study VerDate Mar<15>2010 16:35 Dec 18, 2012 Jkt 229001 will collect information on dosage and referrals from home visiting programs’ management information systems, and will collect information on family outcomes from state and vital records systems. These data will be combined with administrative data to estimate the effects of the home visiting programs on birth outcomes and infant health and health care in the first year, both overall and for groups of families and programs. Data on program implementation will provide information on how local programs operate and the dosage of home visiting services that families receive. Respondents: The respondents will include 20,000 women who are no more than seven months pregnant when they enter the study, 8 state administrators, 68 program managers, and 782 home visitors. Data collection activities will take place over a three-year period. The annual burden on the public for these activities is estimated to be 2,435 hours over a three year period (approximately 21 minutes per person over three years). Copies of the proposed instruments and brief project description may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: OPRE Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: OPREinfocollection@acf.hhs.gov. The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. A comment is best assured of having its full effect if it is received within 30 days of this publication. Written comments and recommendations for the proposed information collection should be sent directly to Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 75171 DC 20447, Attn: OPRE Reports Clearance Officer. Steven M. Hanmer, Reports Clearance Officer. [FR Doc. 2012–30367 Filed 12–18–12; 8:45 am] BILLING CODE 4184–22–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–0976] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance: Emergency Use Authorization of Medical Products AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by January 18, 2013. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202– 395–7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0595. Also include the FDA docket number found in brackets in the heading of this document. SUMMARY: Ila S. Mizrachi, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 7726, Ila.Mizrachi@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. FOR FURTHER INFORMATION CONTACT: Reporting and Recordkeeping for Emergency Use Authorization of Medical Products (OMB Control Number 0910–0595)—Extension The guidance describes the Agency’s general recommendations and procedures for issuance of emergency E:\FR\FM\19DEN1.SGM 19DEN1

Agencies

[Federal Register Volume 77, Number 244 (Wednesday, December 19, 2012)]
[Notices]
[Page 75171]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Comment Request

    Title: Mother and Infant Home Visiting Program Evaluation--Strong 
Start: Data collection.
    Description: In September 2012, the Administration for Children and 
Families (ACF), the Centers for Medicare and Medicaid Services (CMS), 
and the Health Resources and Services Administration (HRSA) within the 
U.S. Department of Health and Human Services (HHS) launched an 
evaluation called the Mother and Infant Home Visiting Program 
Evaluation--Strong Start (MIHOPE--Strong Start). The study will 
evaluate the effectiveness of two evidence-based home visiting models--
Healthy Families America and Nurse Family Partnership--at improving 
birth outcomes for women who are enrolled in Medicaid. The evaluation 
is part of the Strong Start for Mothers and Newborns initiative, which 
is informing the federal government about the effects of prenatal 
interventions that may provide better care, improved health, and 
reduced medical costs by improving birth outcomes.
    Data collected for MIHOPE-Strong Start will include the following: 
(1) A 20-minute baseline family survey, (2) two-hour semi-structured 
interviews with state administrators of the Maternal, Infant, and Early 
Childhood Home Visiting program, (3) web-based surveys with program 
managers of local home visiting programs, and (4) web-based surveys 
with home visitors in those programs. In addition, the study will 
collect information on dosage and referrals from home visiting 
programs' management information systems, and will collect information 
on family outcomes from state and vital records systems.
    These data will be combined with administrative data to estimate 
the effects of the home visiting programs on birth outcomes and infant 
health and health care in the first year, both overall and for groups 
of families and programs. Data on program implementation will provide 
information on how local programs operate and the dosage of home 
visiting services that families receive.
    Respondents: The respondents will include 20,000 women who are no 
more than seven months pregnant when they enter the study, 8 state 
administrators, 68 program managers, and 782 home visitors. Data 
collection activities will take place over a three-year period. The 
annual burden on the public for these activities is estimated to be 
2,435 hours over a three year period (approximately 21 minutes per 
person over three years).
    Copies of the proposed instruments and brief project description 
may be obtained by writing to the Administration for Children and 
Families, Office of Planning, Research and Evaluation, 370 L'Enfant 
Promenade SW., Washington, DC 20447, Attn: OPRE Reports Clearance 
Officer. All requests should be identified by the title of the 
information collection. Email address: OPREinfocollection@acf.hhs.gov.
    The Department specifically requests comments on (a) whether the 
proposed collection of information is necessary for the proper 
performance of the functions of the agency, including whether the 
information shall have practical utility; (b) the accuracy of the 
agency's estimate of the burden of the proposed collection of 
information; (c) the quality, utility, and clarity of the information 
to be collected; and (d) ways to minimize the burden of the collection 
of information on respondents, including through the use of automated 
collection techniques or other forms of information technology.
    A comment is best assured of having its full effect if it is 
received within 30 days of this publication. Written comments and 
recommendations for the proposed information collection should be sent 
directly to Administration for Children and Families, Office of 
Planning, Research and Evaluation, 370 L'Enfant Promenade SW., 
Washington, DC 20447, Attn: OPRE Reports Clearance Officer.

Steven M. Hanmer,
Reports Clearance Officer.
[FR Doc. 2012-30367 Filed 12-18-12; 8:45 am]
BILLING CODE 4184-22-M